Qlife Holding AB (OSTO:QLIFE) Change In Receivables : kr2.71 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Change In Receivables?

Qlife Holding AB's change in receivables for the quarter that ended in Sep. 2023 was kr0.86 Mil. It means Qlife Holding AB's Accounts Receivable declined by kr0.86 Mil from Jun. 2023 to Sep. 2023 .

Qlife Holding AB's change in receivables for the fiscal year that ended in Dec. 2022 was kr4.04 Mil. It means Qlife Holding AB's Accounts Receivable declined by kr4.04 Mil from Dec. 2021 to Dec. 2022 .

Qlife Holding AB's Accounts Receivable for the quarter that ended in Sep. 2023 was kr0.70 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Qlife Holding AB's Days Sales Outstanding for the three months ended in Sep. 2023 was 1,413.36.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Qlife Holding AB's liquidation value for the three months ended in Sep. 2023 was kr-48.41 Mil.

Qlife Holding AB Change In Receivables Historical Data

The historical data trend for Qlife Holding AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Change In Receivables Chart

Qlife Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Change In Receivables

-10.65

-2.03

4.04

Qlife Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial														-7.57	9.26	-1.41	-6.00	0.86

Qlife Holding AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.71 Mil.

Qlife Holding AB (OSTO:QLIFE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Qlife Holding AB's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.697	/	0.045	*	91
=	1,413.36

2. In Ben Graham's calculation of liquidation value, Qlife Holding AB's accounts receivable are only considered to be worth 75% of book value:

Qlife Holding AB's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.632	-	58.504	+	0.75 * 0.697	+	0.5 * 7.872
=	-48.41

Qlife Holding AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Qlife Holding AB (OSTO:QLIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

4HG:Germany

Address

Redaregatan 48, Helsingborg, SWE, SE-252 36

Website

https://www.qlifeholding.com

Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines